As a Global Therapeutics Portfolio Manager, you will lead and own the small molecule portfolio strategy setting short and long-term initiatives for the existing product portfolio and innovation roadmap in line with our core vertical markets we serve within the small molecule space, including oral solid dose, generics, OTC / consumer and animal health.
You will be a key member and leader of the Biopharma “Pod” collaborating with “Pod” team members from Marketing and RD&A. With your leadership in innovation and expertise in product management, you will ensure successful development and commercialization of innovative new products along with the management of existing product offerings.
There will also be close collaboration with commercial sales and business development teams so you can establish a deep understanding of customer pain points, addressable markets, competition and other key considerations.
You will also act as a liaison between commercial teams and the technology (operations) as a customer advocate.
Finally, this role will require you to have a deep understanding of Kerry technologies and capabilities, being able to successfully navigate a complex matrixed environment so you can leverage relationships and maximize Kerry’s serviceability in new or underpenetrated markets.